Product Center

GN (Gram-Negative) Broth, 8 mL



Cat. # Description Qty. Unit
221729 GN (Gram-Negative) Broth, 8 mL
10 SP

Intended Use:

GN Broth is used for the selective enrichment of Salmonella and Shigella.


Catalog # Description Quantity Unit
221729 GN (Gram-Negative) Broth, 8 mL
10 SP

BBL™ GN Broth
Revision: 11     Revision Date: 01/01/2011    

Intended Use:

GN Broth is used for the selective enrichment of Salmonella and Shigella.



Product Summary:

GN (Gram Negative) Broth was developed by Hajna as an enrichment medium for the recovery of Salmonella and Shigella from clinical specimens.1,2 Croft and Miller succeeded in isolating more Shigella strains by use of this medium, rather than by direct streaking.3 Taylor and Schelhart reported that GN Broth enhanced the isolation of enteric pathogens, producing a 53% increase in Shigella and 36% increase in Salmonella as compared to direct streaking.4

GN Broth currently is recommended for use in the microbiological examination of foods.5



User Quality Control:

See "Quality Control Procedures."

Quality Control requirements must be performed in accordance with applicable local, state and/or federal regulations or accreditation requirements and your laboratory's standard Quality Control procedures. It is recommended that the user refer to pertinent CLSI (formerly NCCLS) guidance and CLIA regulations for appropriate Quality Control practices.



Reagents:

GN Broth
  Approximate Formula* Per Liter Purified Water
  Pancreatic Digest of Casein  10.0   g
  Peptic Digest of Animal Tissue  10.0   g
  Dextrose  1.0   g
  D-Mannitol  2.0   g
  Sodium Citrate  5.0   g
  Sodium Desoxycholate  0.5   g
  Dipotassium Phosphate  4.0   g
  Monopotassium Phosphate  1.5   g
  Sodium Chloride  5.0   g
  *Adjusted and/or supplemented as required to meet performance criteria.


Warnings and Precautions:

For in vitro Diagnostic Use.

Tubes with tight caps should be opened carefully to avoid injury due to breakage of glass.

Pathogenic microorganisms, including hepatitis viruses and Human Immunodeficiency Virus, may be present in clinical specimens. "Standard Precautions"6-9 and institutional guidelines should be followed in handling all items contaminated with blood and other body fluids. After use, prepared tubes, specimen containers and other contaminated materials must be sterilized by autoclaving before discarding.



Information shown on this page is a short summary extracted from the QC/PI Manual, available as a PDF under the Related Documents section of this page.